Skip to main content
Erschienen in: European Journal of Pediatrics 4/2010

01.04.2010 | Original Paper

Mycoplasma pneumoniae associated opsoclonus–myoclonus syndrome in three cases

verfasst von: Benedikt Maria Huber, Susi Strozzi, Maja Steinlin, Christoph Aebi, Simon Fluri

Erschienen in: European Journal of Pediatrics | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Opsoclonus–myoclonus syndrome (OMS) is a rare acquired movement disorder occurring in all age groups, predominantly in infants. Although the exact pathogenesis is still undefined, there is strong evidence for a paraneoplastic or parainfectious immune process resulting in central nervous system dysfunction. Mycoplasma pneumoniae has been implicated in a number of immune-mediated neurologic diseases [28]. However, the association of M. pneumoniae and opsoclonus–myoclonus–ataxia syndrome is not well established so far. We present three cases with opsoclonus–myoclonus–ataxia syndrome in adolescents following an infection with M. pneumoniae. Monophasic disease course and full recovery correspond to the favorable prognosis known from parainfectious cases in young adults. This should affect therapeutic consideration. OMS should be added to the spectrum of M. pneumoniae-associated neurologic complications. Nevertheless, neuroblastoma has to be ruled out in all cases of OMS.
Literatur
1.
Zurück zum Zitat Al-Lozi MT, Pestronk A (2001) Paraneoplastic neurologic syndromes. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds) Harrison’s principles of internal medicine, 15th edn. McGraw-Hill, NewYork, pp 636–642 Al-Lozi MT, Pestronk A (2001) Paraneoplastic neurologic syndromes. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds) Harrison’s principles of internal medicine, 15th edn. McGraw-Hill, NewYork, pp 636–642
2.
Zurück zum Zitat Bataller L, Graus F, Saiz A, Vichez JJ (2001) Spanish Opsoclonus–Myoclonus Study Group. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus–myoclonus. Brain 124:437–443CrossRefPubMed Bataller L, Graus F, Saiz A, Vichez JJ (2001) Spanish Opsoclonus–Myoclonus Study Group. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus–myoclonus. Brain 124:437–443CrossRefPubMed
3.
Zurück zum Zitat Bataller L, Rosenfeld MR, Graus F, Vilchez JJ, Cheung NK, Dalmau J (2003) Autoantigen diversity in the opsoclonus–myoclonus syndrome. Ann Neurol 53:347–353CrossRefPubMed Bataller L, Rosenfeld MR, Graus F, Vilchez JJ, Cheung NK, Dalmau J (2003) Autoantigen diversity in the opsoclonus–myoclonus syndrome. Ann Neurol 53:347–353CrossRefPubMed
4.
Zurück zum Zitat Chemli J, Ketata S, Dalhoumi A, Ajmi H, Hassayoun S, Fodha I et al (2007) Opsoclonus–myoclonus syndrome associated with Mycoplasma pneumoniae infection. Arch Pediatr 14:1003–1006CrossRefPubMed Chemli J, Ketata S, Dalhoumi A, Ajmi H, Hassayoun S, Fodha I et al (2007) Opsoclonus–myoclonus syndrome associated with Mycoplasma pneumoniae infection. Arch Pediatr 14:1003–1006CrossRefPubMed
5.
Zurück zum Zitat Connolly AM, Pestronk A, Mehta S, Pranzatelli MR, Noetzel MJ (1997) Serum autoantibodies in childhood opsoclonus–myoclonus syndrome: an analysis of antigenic targets in neural tissues. J Pediatr 130:878–884CrossRefPubMed Connolly AM, Pestronk A, Mehta S, Pranzatelli MR, Noetzel MJ (1997) Serum autoantibodies in childhood opsoclonus–myoclonus syndrome: an analysis of antigenic targets in neural tissues. J Pediatr 130:878–884CrossRefPubMed
6.
Zurück zum Zitat Daxboeck F, Krause R, Wenisch C (2003) Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect 9:263–273CrossRefPubMed Daxboeck F, Krause R, Wenisch C (2003) Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect 9:263–273CrossRefPubMed
7.
Zurück zum Zitat Daxboeck F (2006) Mycoplasma pneumoniae central nervous system infections. Curr Opin Neurol 19:374–378CrossRefPubMed Daxboeck F (2006) Mycoplasma pneumoniae central nervous system infections. Curr Opin Neurol 19:374–378CrossRefPubMed
8.
Zurück zum Zitat Guleria R, Nisar N, Chawla TC, Biswas NR (2005) Mycoplasma pneumoniae and central nervous system complications: a review. J Lab Clin Med 146:55–63CrossRefPubMed Guleria R, Nisar N, Chawla TC, Biswas NR (2005) Mycoplasma pneumoniae and central nervous system complications: a review. J Lab Clin Med 146:55–63CrossRefPubMed
9.
Zurück zum Zitat Kinsbourne M (1962) Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiatry 25:271–276CrossRef Kinsbourne M (1962) Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiatry 25:271–276CrossRef
10.
Zurück zum Zitat Klein A, Schmitt B, Boltshauser E (2007) Long-term outcome of ten children with opsoclonus–myoclonus syndrome. Eur J Pediatr 166:359–363CrossRefPubMed Klein A, Schmitt B, Boltshauser E (2007) Long-term outcome of ten children with opsoclonus–myoclonus syndrome. Eur J Pediatr 166:359–363CrossRefPubMed
11.
Zurück zum Zitat Korfei M, Fühlhuber V, Schmidt-Wöll T, Kaps M, Preissner KT, Blaes F (2005) Functional characterisation of autoantibodies from patients with pediatric opsoclonus–myoclonus syndrome. J Neuroimmunol 170:150–157CrossRefPubMed Korfei M, Fühlhuber V, Schmidt-Wöll T, Kaps M, Preissner KT, Blaes F (2005) Functional characterisation of autoantibodies from patients with pediatric opsoclonus–myoclonus syndrome. J Neuroimmunol 170:150–157CrossRefPubMed
12.
Zurück zum Zitat McCormack WM (2001) Mycoplasma infections (2001). In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds) Harrison’s principles of internal medicine, 15th edn. McGraw-Hill, NewYork, pp 1073–1075 McCormack WM (2001) Mycoplasma infections (2001). In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds) Harrison’s principles of internal medicine, 15th edn. McGraw-Hill, NewYork, pp 1073–1075
13.
Zurück zum Zitat Mitchell WG, Brumm VL, Azen CG, Patterson KE, Aller SK, Rodriguez J (2005) Longitudinal neurodevelopmental evaluation of children with opsoclonus–ataxia. Pediatrics 116:901–907CrossRefPubMed Mitchell WG, Brumm VL, Azen CG, Patterson KE, Aller SK, Rodriguez J (2005) Longitudinal neurodevelopmental evaluation of children with opsoclonus–ataxia. Pediatrics 116:901–907CrossRefPubMed
14.
Zurück zum Zitat Pranzatelli MR, Huang Y, Tate E, Stanley M, Noetzel MJ, Gospe SM Jr et al (1995) Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus–myoclonus syndrome. Ann Neurol 37:189–197CrossRefPubMed Pranzatelli MR, Huang Y, Tate E, Stanley M, Noetzel MJ, Gospe SM Jr et al (1995) Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus–myoclonus syndrome. Ann Neurol 37:189–197CrossRefPubMed
15.
Zurück zum Zitat Pranzatelli MR, Hyland K, Tate ED, Arnold LA, Allison TJ, Soori GS (2004) Evidence of cellular immue activation in children with opsoclonus–myoclonus: cerebrospinal fluid neopterin. J Child Neurol 19:919–924PubMed Pranzatelli MR, Hyland K, Tate ED, Arnold LA, Allison TJ, Soori GS (2004) Evidence of cellular immue activation in children with opsoclonus–myoclonus: cerebrospinal fluid neopterin. J Child Neurol 19:919–924PubMed
16.
Zurück zum Zitat Pranzatelli MR, Tate ED, Travelstead AL, Barbosa J, Bergamini RA, Civitello L et al (2006) Rituximab (anti-CD20) adjunctive therapy for opsoclonus–myoclonus syndrome. J Pediatr Hematol Oncol 28:585–593CrossRefPubMed Pranzatelli MR, Tate ED, Travelstead AL, Barbosa J, Bergamini RA, Civitello L et al (2006) Rituximab (anti-CD20) adjunctive therapy for opsoclonus–myoclonus syndrome. J Pediatr Hematol Oncol 28:585–593CrossRefPubMed
17.
Zurück zum Zitat Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Lee ND, Fisher J et al (2004) Immunophenotype of blood lymphocytes in neuroblastoma-associated opsoclonus–myoclonus. J Pediatr Hematol Oncol 26:718–723CrossRefPubMed Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Lee ND, Fisher J et al (2004) Immunophenotype of blood lymphocytes in neuroblastoma-associated opsoclonus–myoclonus. J Pediatr Hematol Oncol 26:718–723CrossRefPubMed
18.
Zurück zum Zitat Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Moticka EJ, Franz DN et al (2004) B- and T-cell markers in opsoclonus–myoclonus syndrome. Neurology 62:1526–1532PubMed Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Moticka EJ, Franz DN et al (2004) B- and T-cell markers in opsoclonus–myoclonus syndrome. Neurology 62:1526–1532PubMed
19.
Zurück zum Zitat Raffaghello L, Conte M, De Grandis E, Pistoia V (2009) Immunological mechanism inopsoclonus–myoclonus associated neuroblastoma. Eur J Paediatr Neurol 13:219–223CrossRefPubMed Raffaghello L, Conte M, De Grandis E, Pistoia V (2009) Immunological mechanism inopsoclonus–myoclonus associated neuroblastoma. Eur J Paediatr Neurol 13:219–223CrossRefPubMed
20.
Zurück zum Zitat Sottini A, Micheli R, Ghidini C, Valotti M, Airo P, Caimi L et al (2007) T-lymphocyte production, function and death in children who recovered from opsoclonus–myoclonus syndrome. Pediatr Hematol Oncol 24:23–27CrossRefPubMed Sottini A, Micheli R, Ghidini C, Valotti M, Airo P, Caimi L et al (2007) T-lymphocyte production, function and death in children who recovered from opsoclonus–myoclonus syndrome. Pediatr Hematol Oncol 24:23–27CrossRefPubMed
21.
Zurück zum Zitat Tate ED, Alison TJ, Pranzatelli MR, Verhuldt SJ (2005) Neuroepidemiological trends in 105 US cases of pediatric opsoclonus–myoclonus syndrome. J Pediatr Oncol Nurs 22:8–19CrossRefPubMed Tate ED, Alison TJ, Pranzatelli MR, Verhuldt SJ (2005) Neuroepidemiological trends in 105 US cases of pediatric opsoclonus–myoclonus syndrome. J Pediatr Oncol Nurs 22:8–19CrossRefPubMed
22.
Zurück zum Zitat Tsiodras S, Kelesidis I, Kelesidis T, Stamboulis E, Giamarellou H (2005) Central nervous system manifestations of Mycoplasma pneumoniae infections. J Infect 51:343–354CrossRefPubMed Tsiodras S, Kelesidis I, Kelesidis T, Stamboulis E, Giamarellou H (2005) Central nervous system manifestations of Mycoplasma pneumoniae infections. J Infect 51:343–354CrossRefPubMed
23.
Zurück zum Zitat Verma A, Brozman B (2002) Opsoclonus–myoclonus syndrome following Epstein–Barr virus infection. Neurology 58:1131–1132PubMed Verma A, Brozman B (2002) Opsoclonus–myoclonus syndrome following Epstein–Barr virus infection. Neurology 58:1131–1132PubMed
24.
Zurück zum Zitat Waites KB, Talkington DF (2004) Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 4:697–728CrossRef Waites KB, Talkington DF (2004) Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 4:697–728CrossRef
25.
Zurück zum Zitat Waris ME, Toikka P, Saarinen T, Nikkari S, Meurman O, Vainionpää R et al (1998) Diagnosis of Mycoplasma pneumoniae in children. J Clin Microbiol 36:3155–3159PubMed Waris ME, Toikka P, Saarinen T, Nikkari S, Meurman O, Vainionpää R et al (1998) Diagnosis of Mycoplasma pneumoniae in children. J Clin Microbiol 36:3155–3159PubMed
26.
Zurück zum Zitat Wilson J (2006) Neuroimmunology of dancing eye syndrome in children. Developmental Medicine Child Neurology 48:693–696CrossRefPubMed Wilson J (2006) Neuroimmunology of dancing eye syndrome in children. Developmental Medicine Child Neurology 48:693–696CrossRefPubMed
28.
Zurück zum Zitat Yiş U, Kurul SH, Cakmakçi H, Dirik E (2008) Mycoplasma pneumoniae: nervous system complications in childhood and review of the literature. Eur J Pediatr 167:973–978CrossRefPubMed Yiş U, Kurul SH, Cakmakçi H, Dirik E (2008) Mycoplasma pneumoniae: nervous system complications in childhood and review of the literature. Eur J Pediatr 167:973–978CrossRefPubMed
Metadaten
Titel
Mycoplasma pneumoniae associated opsoclonus–myoclonus syndrome in three cases
verfasst von
Benedikt Maria Huber
Susi Strozzi
Maja Steinlin
Christoph Aebi
Simon Fluri
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
European Journal of Pediatrics / Ausgabe 4/2010
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-009-1048-3

Weitere Artikel der Ausgabe 4/2010

European Journal of Pediatrics 4/2010 Zur Ausgabe

Review

Eponym

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.